Company / Shareholders' Equity
Day One Biopharmaceuticals, Inc. Shareholders' Equity History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$441.2M
FY2025
5-year range
$281.1M / $502.8M
FY2021-FY2025
Trend
-12.3%
vs FY2024
Sector context
#104 of 215
Health Care
What the data says
At $441M, Day One Biopharmaceuticals, Inc.'s shareholders' equity ranks #104 of 215 in the Health Care sector. Improved from $347M to $441M over the past 2 years.
Based on SEC 10-K filings.
$441M in FY2025 with a 3-year CAGR of +9.9%.
Improved from $347M to $441M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +9.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#104 of 215 in Health CareTop 48% of 215This company $441.2M Sector average $2.6B
▼
-82.8% below sector average
Key checks
Key Insights
- 3-year CAGR of +9.9%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 12.3% year-over-year.
- Ranks #104 out of 215 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2024.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $441.2M | -12.3% |
| FY2024 | $502.8M | +45.1% |
| FY2023 | $346.5M | +4.4% |
| FY2022 | $332.0M | +18.1% |
| FY2021 | $281.1M | +618.7% |
| FY2020 | -$54.2M | -407.9% |
| FY2019 | -$10.7M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026